Cellectis Ownership | Who Owns Cellectis?
Cellectis Ownership Summary
Cellectis is owned by 5.66% institutional investors, 3.87% insiders, and 90.48% retail investors. Long focus capital management is the largest institutional shareholder, holding 4.61% of CLLS shares. American Funds SMALLCAP World A is the top mutual fund, with 1.85% of its assets in Cellectis shares.
CLLS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Cellectis | 5.66% | 3.87% | 90.48% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Long focus capital management | 4.62M | 4.61% | $8.31M |
Capital investors | 1.85M | 1.85% | $3.33M |
Ubs asset management americas | 1.44M | 1.44% | $2.59M |
Millennium management | 534.55K | 0.53% | $962.19K |
Baillie gifford | 290.43K | 0.29% | $522.77K |
Ubs group | 229.08K | 0.23% | $412.35K |
Macquarie group | 226.88K | 0.23% | $408.00K |
Lpl financial | 91.79K | 0.13% | $171.64K |
Morgan stanley | 86.33K | 0.12% | $161.43K |
Two sigma investments, lp | 27.32K | 0.03% | $49.18K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Long focus capital management | 4.62M | 0.27% | $8.31M |
First affirmative financial network | 25.86K | 0.03% | $46.55K |
Xtx topco | 10.53K | 0.00% | $18.95K |
Pom investment strategies | 495.00 | 0.00% | $891.00 |
Ubs asset management americas | 1.44M | 0.00% | $2.59M |
Capital investors | 1.85M | 0.00% | $3.33M |
Macquarie group | 226.88K | 0.00% | $408.00K |
Millennium management | 534.55K | 0.00% | $962.19K |
Baillie gifford | 290.43K | 0.00% | $522.77K |
Harbour investments | 4.50K | 0.00% | $8.10K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Millennium management | 534.55K | 0.00% | 534.55K |
Ubs group | 229.08K | 0.00% | 229.08K |
Acadian asset management | 19.92K | 0.00% | 19.92K |
Wells fargo & company/mn | 24.59K | - | 12.50K |
Lpl financial | 91.79K | 0.00% | 10.44K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Principal financial group | - | - | -411.80K |
Baillie gifford | 290.43K | 0.00% | -403.51K |
Kbc group nv | - | - | -163.45K |
Oppenheimer | - | - | -133.89K |
Susquehanna group, llp | - | - | -13.01K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Millennium management | 534.55K | 0.00% | 534.55K | $962.19K |
Ubs group | 229.08K | 0.00% | 229.08K | $412.35K |
Acadian asset management | 19.92K | 0.00% | 19.92K | $34.00K |
Advisor group | 303.00 | - | 303.00 | $546.00 |
Principal securities | 52.00 | - | 52.00 | $94.00 |
Sold Out
Holder | Change |
---|---|
Financial gravity asset management | -1.00 |
Toronto dominion bank | -31.00 |
Frg family wealth advisors | -80.00 |
Qube research | -112.00 |
Old point trust & financial services n a | -250.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 20 | -31.03% | 5,664,103 | -42.00% | 5 | 5.94% | 8 | 33.33% | 5 | -28.57% |
Sep 30, 2024 | 29 | -3.33% | 9,766,379 | -0.06% | 9 | 5.27% | 6 | -25.00% | 7 | - |
Jun 30, 2024 | 30 | -6.25% | 9,772,626 | -0.83% | 13 | 4.33% | 8 | -33.33% | 7 | 40.00% |
Mar 31, 2024 | 32 | -8.57% | 9,854,602 | 0.39% | 17 | 5.68% | 12 | -14.29% | 5 | -28.57% |
Dec 31, 2023 | 35 | 12.90% | 9,816,725 | -14.49% | 17 | 4.14% | 14 | 27.27% | 7 | 16.67% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
American Funds SMALLCAP World A | 1.85M | 1.85% | - |
UBS Lux Dgtl Hlth Eq Fd seeding P acc | 1.44M | 1.44% | - |
UBS (Lux) Digital Health Equity SB USD | 1.44M | 1.44% | - |
Principal U.S. Small Cap Equity | 289.60K | 0.29% | -4.40K |
Delaware Healthcare I | 226.88K | 0.23% | - |
Macquarie Healthcare I | 226.88K | 0.23% | - |
Galileo - Biotech Innovation Fund S USD | 226.07K | 0.23% | - |
Principal SmallCap R5 | 199.15K | 0.20% | -90.45K |
Baillie Gifford Global Discovery A Acc | 147.53K | 0.15% | -1.93K |
Vanguard International Explorer Inv | 122.03K | 0.12% | - |
CLLS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools